CSTF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.949000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.481400E-01
Normal-vs-Stage2
4.252200E-01
Normal-vs-Stage3
9.127200E-01
Normal-vs-Stage4
4.416800E-01
Stage1-vs-Stage2
7.667600E-01
Stage1-vs-Stage3
3.859400E-01
Stage1-vs-Stage4
9.352800E-01
Stage2-vs-Stage3
2.926800E-01
Stage2-vs-Stage4
8.999000E-01
Stage3-vs-Stage4
4.237800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.076200E-01
Normal-vs-AfricanAmerican
4.241400E-01
Normal-vs-Asian
4.851800E-01
Caucasian-vs-AfricanAmerican
9.866400E-01
Caucasian-vs-Asian
4.452000E-01
AfricanAmerican-vs-Asian
6.613800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.767400E-01
Normal-vs-Female
5.232400E-01
Male-vs-Female
5.060200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.014000E-01
Normal-vs-Age(41-60Yrs)
3.799800E-01
Normal-vs-Age(61-80Yrs)
5.927800E-01
Normal-vs-Age(81-100Yrs)
3.277400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.910600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.445200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.539600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.428000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.029400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.118200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.802200E-01
Normal-vs-Daily Drinker
7.690400E-01
Normal-vs-Weekly Drinker
5.559000E-01
Normal-vs-Occasional Drinker
4.024200E-01
Normal-vs-Social Drinker
5.473000E-01
Non Drinker-vs-Daily Drinker
7.483000E-01
Non Drinker-vs-Weekly Drinker
8.192000E-01
Non Drinker-vs-Occasional Drinker
2.031800E-01
Non Drinker-vs-Social Drinker
8.967000E-01
Daily Drinker-vs-Weekly Drinker
6.690600E-01
Daily Drinker-vs-Occasional Drinker
1.520970E-01
Daily Drinker-vs-Social Drinker
8.632800E-01
Weekly Drinker-vs-Occasional Drinker
3.384800E-01
Weekly Drinker-vs-Social Drinker
7.465400E-01
Occasional Drinker-vs-Social Drinker
1.826240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.091800E-01
Normal-vs-Grade 2
9.028400E-01
Normal-vs-Grade 3
8.388400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.838600E-03
Grade 1-vs-Grade 3
3.418500E-04
Grade 1-vs-Grade 4
9.091800E-01
Grade 2-vs-Grade 3
2.349400E-01
Grade 2-vs-Grade 4
9.028400E-01
Grade 3-vs-Grade 4
8.388400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.089600E-01
Normal-vs-NonDiabetic
5.861000E-01
Diabetic-vs-NonDiabetic
9.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.126000E-01
Normal-vs-NoPancreatitis
5.822000E-01
Pancreatitis-vs-NoPancreatitis
7.590200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.657000E-01
Normal-vs-N1
4.637200E-01
N0-vs-N1
4.643600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.166760E-01
Normal-vs-TP53-NonMutant
6.791800E-01
TP53-Mutant-vs-TP53-NonMutant
2.00609999999601E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
